Akanda (AKAN) Receivables - Net (2021 - 2025)

Akanda's (AKAN) quarterly Receivables - Net came in at $97627.0 in Q4 2025, down 73.65% year-on-year from $370537.0 in Q4 2024, and down 73.65% quarter-over-quarter from $370537.0 in Q4 2024.

Akanda (AKAN) Receivables - Net (2021 - 2025) Analysis & Trends

Akanda's Receivables - Net history runs 5 years deep, the most recent figure standing at $97627.0 for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 73.65% year-over-year to $97627.0 in Q4 2025; TTM through Dec 2025 was $97627.0, a 73.65% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, up 277.82% from the prior year.
  • Receivables - Net eased to $97627.0 in Q4 2025 per AKAN's latest filing, from $370537.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $720085.0 in Q4 2022 and bottomed at $97627.0 in Q4 2025.
  • The 5-year median for Receivables - Net is $242357.0 (2021), against an average of $317278.2.
  • Across the five-year window, Receivables - Net soared 197.12% in 2022 and slumped 78.37% in 2023, its largest moves.
  • Year by year, Receivables - Net stood at $242357.0 in 2021, then surged by 197.12% to $720085.0 in 2022, then slumped by 78.37% to $155785.0 in 2023, then jumped by 137.85% to $370537.0 in 2024, then plunged by 73.65% to $97627.0 in 2025.
  • Per Business Quant, the three latest AKAN Receivables - Net figures stand at $97627.0 (Q4 2025), $370537.0 (Q4 2024), and $155785.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Akanda 556,353.85 556,353.85 -

Historic Data

Download Data
DateValue
Dec 31, 2025 97,627.00
Dec 31, 2025 97,627.00
Dec 31, 2024 370,537.00
Dec 31, 2024 370,537.00
Dec 31, 2023 155,785.00
Dec 31, 2023 155,785.00
Dec 31, 2022 720,085.00
Dec 31, 2022 720,085.00
Dec 31, 2021 242,357.00
Dec 31, 2021 242,357.00